- Home
- GAUZ vs ACIU Comparison
GAUZ vs ACIU Comparison
Compare GAUZ & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAUZ
- ACIU
- Stock Information
- Founded
- GAUZ 2009
- ACIU 2003
- Country
- GAUZ Israel
- ACIU Switzerland
- Employees
- GAUZ N/A
- ACIU N/A
- Industry
- GAUZ Industrial Machinery/Components
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- GAUZ Miscellaneous
- ACIU Health Care
- Exchange
- GAUZ Nasdaq
- ACIU Nasdaq
- Market Cap
- GAUZ 180.1M
- ACIU 168.7M
- IPO Year
- GAUZ 2024
- ACIU 2016
- Fundamental
- Price
- GAUZ $8.60
- ACIU $1.88
- Analyst Decision
- GAUZ Strong Buy
- ACIU Strong Buy
- Analyst Count
- GAUZ 4
- ACIU 1
- Target Price
- GAUZ $15.50
- ACIU $12.00
- AVG Volume (30 Days)
- GAUZ 23.9K
- ACIU 116.1K
- Earning Date
- GAUZ 08-07-2025
- ACIU 08-05-2025
- Dividend Yield
- GAUZ N/A
- ACIU N/A
- EPS Growth
- GAUZ N/A
- ACIU N/A
- EPS
- GAUZ N/A
- ACIU N/A
- Revenue
- GAUZ $101,165,000.00
- ACIU $32,014,254.00
- Revenue This Year
- GAUZ $28.49
- ACIU N/A
- Revenue Next Year
- GAUZ $47.77
- ACIU $533.21
- P/E Ratio
- GAUZ N/A
- ACIU N/A
- Revenue Growth
- GAUZ 18.63
- ACIU 91.20
- 52 Week Low
- GAUZ $6.78
- ACIU $1.43
- 52 Week High
- GAUZ $14.44
- ACIU $4.41
- Technical
- Relative Strength Index (RSI)
- GAUZ N/A
- ACIU 51.75
- Support Level
- GAUZ N/A
- ACIU $1.83
- Resistance Level
- GAUZ N/A
- ACIU $2.10
- Average True Range (ATR)
- GAUZ 0.00
- ACIU 0.15
- MACD
- GAUZ 0.00
- ACIU -0.00
- Stochastic Oscillator
- GAUZ 0.00
- ACIU 44.44
About GAUZ Gauzy Ltd. Ordinary Shares
Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.